review of existing studies on ASL in dementia Marion Smits, MD PhD
|
|
- Beverly Wiggins
- 5 years ago
- Views:
Transcription
1 review of existing studies on ASL in dementia Marion Smits, MD PhD Associate Professor of Neuroradiology Department of Radiology, Erasmus MC, Rotterdam (NL) Alzheimer Centre South-West Netherlands, Rotterdam (NL) source: depositphotos.com 1&
2 frontotemporal&demen2a& HIV&demen2a& Cor2cobasal°enera2on& Parkinson s&demen2a& Lewy&Body&demen2a& Alzheimer s+disease+ Seman2c&demen2a& mul2system&atrophy& Primary&progressive&aphasia& Creutzfeld;Jakob&disease& Pick s&disease& Vascular&demen2a& Progressive&supranuclear&palsy& Alzheimer s Association 2013: 2&
3 Alzheimer s,disease,is,not,, just,memory,loss,,alzheimer s,kills, Alzheimer s Association 2013: Biomarker development! Therapeutic interventions most effective in early stages! maybe even in the preclinical stage early disease detection required.! Need for quantitative outcome measures in clinical trials disease monitoring required. 3&
4 Molecular biomarkers PiB-PET (amyloid deposition). CSF Aβ 1-42 (amyloid deposition). CSF tau protein (neuronal degeneration).! high sensitivity to early disease and histological measures of pathology.! limited sensitivity to clinical status and capacity to track disease progression. Functional biomarkers! Reflect synaptic activity more sensitive to disease activity.! Quantification allows for longitudinal measurements of drug effects. FDG-PET (glucose metabolism). ASL-MRI (cerebral blood flow). 4&
5 Alzheimer frontotemporal vascular THE DEMENTIAS 5&
6 Alzheimer s disease Clinical presentation! progressive memory impairment.! loss of episodic memory.! disorientation in time and place.! disturbance of executive and visuospatial function, praxis.! later: focal neurological deficits aphasia. Pathology! atrophy enlargement of ventricles and sulci.! entorhinal cortex limbic system higher order cortex.! neurofibrillary tangles and neuritic plaques. 6&
7 hippocampal atrophy temporal atrophy parietal atrophy global atrophy ASL in Alzheimer s disease! Regional hypoperfusion (~ regional hypometabolism)! posterior cingulate cortex (PCC)! precuneus! inferior parietal lobe! lateral prefrontal cortex.! Global hypoperfusion Asslani et al. J Cereb Blood Flow Metab 2008;28:725. 7&
8 ASL for early diagnosis of dementia * p<0.01 ** p<0.001 Regions involved in dementia Regions spared in dementia Steketee et al. submitted Hypoperfusion and atrophy! Hypoperfusion commonly exceeds atrophy precedes tissue loss.! Discordant regions! hippocampus! anterior cingulate cortex. Alsop et al. Neuroimage 2008;42:1267 8&
9 hypoperfusion atrophy Alsop et al. Neuroimage 2008;42:1267 hypoperfusion atrophy Alsop et al. Neuroimage 2008;42:1267 9&
10 The hippocampus Hyper perfusion! decoupling with vascular compromise! local inflammation! plastic remodelling! compensatory response! methodology? Hypo perfusion! before PVE correction Binnewijzend et al. Radiology 2013;267:221 Often not imaged. Alsop et al. Neuroimage 2008;42:1267 Comparison of ASL with FDG-PET! 15 AD vs 19 controls.! High concordance with simultaneous ASL and FDG-PET.! Comparable diagnostic accuracy (AUC)! ASL 0.94 ( )! PET 0.92 ( ). Chen et al. Neurology 2011;77: &
11 ASL in prodromal AD: MCI! Important target population for disease modifying therapeutics.! Regional hypoperfusion (consistent with FDG-PET & AD)! PCC! precuneus! parietal regions! to lesser extent than in AD.! Also hyperperfusion Dai et al. Radiology 2009;250:856! hippocampus! amygdala! striatum. Correlation with disease severity! Studies are scarce.! Generally correlated with MMSE (crude!).! Regional hypoperfusion! (lateral) parietal and parieto-occipital cortices! early stage AD or MCI: PCC. 11&
12 AD converters precuneus middle cingulum inferior parietal lobe middle frontal cortex Predictors of decline precuneus (selective attention, activities of daily living, dementia score) inferior parietal lobe (dementia score) middle cingulum (dementia score) Chao et al. Alzheimer Dis Assoc Disord 2010;24:19 large patient population 71 AD patients 31 MCI patients 70 subjective complaints (SC) correlation with MMSE parietal cortex precuneus PCC Binnewijzend et al. Radiology 2013;267:221 12&
13 Task-related ASL MRI in early AD! MCI versus controls Xu et al. Neurology 2007;69:1650! resting CBF in precuneus! extent of hypoperfusion in precuneus PCC during memory encoding task! CBF in MTL with task compared with rest in controls CBF.! APOE-ε4 carriers Fleisher et al. Neurobiol Aging 2009;30:1737! resting CBF in the MTL! blunted increase during face-name memory encoding task. Task-related ASL accentuates group differences. Frontotemporal dementia Incidence! 5-10% of cases of dementia! family history (1 st degree) positive in 40% Clinical presentation! psychiatric symptoms: depression, behavioural and personality changes! memory deficits! later: language impairment (progressive mutism) Subtypes! behavioural variant FTD: bvftd! semantic dementia: SD! progressive nonfluent aphasia: PNFA 13&
14 temporal and frontal atrophy asymmetrical left sided temporal lobe atropy Semantic dementia 14&
15 ASL in FTD! Studies are scarce.! Regional hypoperfusion! prefrontal cortex! insula.! No studies on specific subtypes. Semantic dementia marked hypoperfusion bilateral insula left >> right hyperfusion temporal lobe 15&
16 Hu et al. Neurology 2010;75:881 FTD<controls FTD>AD regional hypoperfusion regional hyperperfusion Du et al. Neurology 2006;67: &
17 FTD versus controls concordance atrophy with CBF - R prefrontal cortex - medial frontal lobe discordance atrophy without CBF - premotor cortex Shimizu et al. Brain Im&Beh 2010;4:46 Vascular dementia Incidence! most common cause of dementia after Alzheimer disease! association with vascular risk factors Clinical presentation! more sudden onset than Alzheimer disease! stepwise pattern with sudden onsets of deterioration! more commonly small vessel disease with gradual deterioration 17&
18 multiple lacunar infarcts carotid occlusion frontal and parietal infarcts in the dominant hemisphere ASL in vascular dementia (VaD)! Largely un(der)explored.! No coherent regional metabolic/perfusion pattern described! preferential changes in frontal lobes have been reported! generally no PVE correction in PET/SPECT studies! disruption of (frontal) cortical-subcortical connections.! ASL may show tissue at risk for future infarcts! resting CBF! reactivity measurements of cerebrovascular reserve.! ASL may establish diagnosis: perfusion (rest/challenge). 18&
19 Alzheimer s disease vascular dementia Hendrikse et al. NeuroImaging Clin N Am 2012;22:259 ASL in vascular dementia CBF irrespective of atrophy in both AD (n=14) and VaD (n=8) in frontal > parietal lobes in VaD > AD Inverse correlation of CBF with white matter lesion load in frontal > parietal lobes in VaD > AD ( ) VaD ( ) AD ( ) controls Schuff et al. Alzheimers Dement 2009;5:454 19&
20 high incidence of dementia post-stroke (15-30%) patient population 39 patients (>75y) 6 years post-stroke - 8 with dementia 17 AD patients 29 healthy controls large vessel vascular dementia Firbank et al. Neurology 2011;76:1478 control AD AD: parietal & prefrontal cortex post-stroke no dementia post-stroke: global CBF reduction post-stroke dementia CBF AD > poststroke dementia: global & precentral gyrus Firbank et al. Neurology 2011;76: &
21 Presenile dementia Patient 63y language & memory deficit Ddx: AD / FTD? Presenile dementia Behandeling! Disease onset < 65 years.! Alzheimer s disease most common cause! often with atypical presentation: language, vision, praxis! memory deficits not/less present! no/minor hippocampal atrophy.! Frontotemporal dementia second most common! important differential diagnosis! may be indistinguishable from early AD. 21&
22 Presenile dementia Cholinesterase inhibitors (Reminyl, Exelon )! may positively influence AD disease course! most effective in the early stage of the disease! may negatively influence FTD! may have serious side effects 25-30% discontinue treatment. Prognosis Prognosis is worse in FTD compared with AD! poorer life expectancy (4.2 versus 6.0 years)! faster loss of activities of daily living! faster decline on MMSE (-6.7 versus -2.3) Rascovsky et al. Neurology 2005;65:397 22&
23 ASL for early diagnosis of presenile dementia Patient 63y Control 63y Steketee et al. submitted from group studies to THE PATIENT 23&
24 From group to patient! 13 AD patients, 19 healthy controls! Overall accuracy 70%! Inter-rater reliability κ = 0.7! exceeds structural imaging rating. Raji et al. AJNR 2010;31:847 From group to patient: presenile dementia Threshold CBF values! Thalamus! 42.2 ml/100cc GM/min! sensitivity = 78%! specificity = 65%.! PCC! 52.0 ml/100cc GM/min! sensitivity = 72%! specificity = 70%. Steketee et al. submitted 24&
25 From group to patient Clinical reading of FDG-PET versus ASL-MRI! 2 readers (expert nuclear medicine physicians)! moderate to moderate-strong intermodality agreement (κ = )! sensitivity and specificity comparable between modalities! difference in interobserver agreement! FDG-PET κ = 0.74! ASL-MRI κ = Musiek et al. Alzheimers Dement 2012;8:51 From group to patient Clinical reading of FDG-PET versus ASL-MRI.! 9 young (mean 59y) patients! FDG-PET rated by 2 nuclear medicine physicians! ASL-MRI rated by 2 neuroradiologists.! High intra- and intermodality agreement (κ= )! Diagnostic accuracy (p>0.05)! FDG-PET: 78%! ASL-MRI: 67%. Weyts et al. ESMRMB &
26 Clinical&informa2on& 46&y.o.&female& progressive&neurocogni2ve&deteriora2on& MRI&&&FDG;PET:&?&Alzheimer s&disease& FDG&PET&(27;05;2011)& C/Alzheimer s+disease+ &L&temporal&lobe& &posterior&cingulate& 26&
27 ASL&MRI&(24;05;2011)& C/Normal+ Normal&L&temporal&lobe& Normal&posterior&cingulate& Diagnosis& Paraneoplas2c&limbic&encephali2s& an2;nmda;receptor&encephali2s& Structural&MRI& ~50%&normal& mild&t2;hyperintensi2es&(medial)&temporal&lobes& leptomeningeal&enhancement.& Perfusion& focal&hyperperfusion&(?&related&to&seizures).& FDG&PET& focal&hyper;&and&hypometabolism&& temporal&lobes,&posterior&cingulate.& 27&
28 Conclusions! Published studies mainly on AD! generally small sample size! longitudinal studies lacking! generally established disease stage.! Early stage AD MCI! regional hypoperfusion in PCC and precuneus! accentuated with task-based ASL.! Generally concordance with FDG-PET (glucose metabolism) findings! limited direct comparision of diagnostic accuracy.! Conflicting findings in the hippocampus/mtl.! Gap group individual patient level still needs to be bridged. Curr&Opin&Neurol&2012;25:421& + + Acknowledgments& UCL,+London,+UK+ Prof.&Dr.&X.&Golay& M.&Grade GE+Healthcare& & Dr.&G.C.&Houston& & Porto+University,+PT& & Dr.&A.&Bastos&Leite& & & & AMC,+Amsterdam,+NL& Dr.&A.J.&Nederveen& H.J.&Mutsaerts& Erasmus+MC,+RoEerdam,+NL& R.M.E.&Steketee& E.E.&Bron& 28&
Yin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre
Yin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre Today Introduction to CT Introduction to MRI Introduction to nuclear medicine Imaging the dementias The Brain ~ 1.5
More informationDementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada
Dementia Update October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada Outline New concepts in Alzheimer disease Biomarkers and in vivo diagnosis Future trends
More informationDISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT
Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia DISCLOSURES NONE TO REPORT Freddi Segal Gidan, PA, PhD USC Keck School of Medicine Rancho/USC California Alzheimers Disease
More informationFRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS
FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS Norman L. Foster, M.D. Director, Center for Alzheimer s Care, Imaging and Research Chief, Division of Cognitive Neurology, Department of Neurology
More informationFDG-PET e parkinsonismi
Parkinsonismi FDG-PET e parkinsonismi Valentina Berti Dipartimento di Scienze Biomediche, Sperimentali e Cliniche Sez. Medicina Nucleare Università degli Studi di Firenze History 140 PubMed: FDG AND parkinsonism
More informationRound table: Moderator; Fereshteh Sedaghat, MD, PhD Brain Mapping in Dementias and Non-invasive Neurostimulation
Round table: Moderator; Fereshteh Sedaghat, MD, PhD Brain Mapping in Dementias and Non-invasive Neurostimulation 1. Reflection of Mild Cognitive Impairment (MCI) and Dementias by Molecular Imaging, PET
More informationDiagnosis before NIA AA The impact of FDG PET in. Diagnosis after NIA AA Neuropathology and PET image 2015/10/16
The impact of FDG PET in degenerative dementia diagnosis Jung Lung, Hsu MD, Ph.D (Utrecht) Section of dementia and cognitive impairment Department of Neurology Chang Gung Memorial Hospital, Linkou, Taipei
More informationNIH Public Access Author Manuscript Semin Neurol. Author manuscript; available in PMC 2014 November 14.
NIH Public Access Author Manuscript Published in final edited form as: Semin Neurol. 2013 September ; 33(4): 386 416. doi:10.1055/s-0033-1359312. Neuroimaging Biomarkers of Neurodegenerative Diseases and
More informationForm D1: Clinician Diagnosis
Initial Visit Packet Form D: Clinician Diagnosis NACC Uniform Data Set (UDS) ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by the clinician.
More informationNeuro degenerative PET image from FDG, amyloid to Tau
Neuro degenerative PET image from FDG, amyloid to Tau Kun Ju Lin ( ) MD, Ph.D Department of Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital ( ) Department of Medical Imaging
More informationBrain imaging for the diagnosis of people with suspected dementia
Why do we undertake brain imaging in dementia? Brain imaging for the diagnosis of people with suspected dementia Not just because guidelines tell us to! Exclude other causes for dementia Help confirm diagnosis
More informationDementia: A Comprehensive Update Neuroimaging, CSF, and genetic biomarkers in dementia
Dementia: A Comprehensive Update 2016 Neuroimaging, CSF, and genetic biomarkers in dementia Bradford C. Dickerson, M.D. Associate Professor of Neurology, Harvard Medical School Departments of Neurology
More informationDementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology
Dementia Stephen S. Flitman, MD Medical Director 21st Century Neurology www.neurozone.org Dementia is a syndrome Progressive memory loss, plus Progressive loss of one or more cognitive functions: Language
More informationImaging of Alzheimer s Disease: State of the Art
July 2015 Imaging of Alzheimer s Disease: State of the Art Neir Eshel, Harvard Medical School Year IV Outline Our patient Definition of dementia Alzheimer s disease Epidemiology Diagnosis Stages of progression
More informationConfronting the Clinical Challenges of Frontotemporal Dementia
Confronting the Clinical Challenges of Frontotemporal Dementia A look at FTD s symptoms, pathophysiology, subtypes, as well as the latest from imaging studies. By Zac Haughn, Senior Associate Editor Ask
More informationMoving Targets: An Update on Diagnosing Dementia in the Clinic
Moving Targets: An Update on Diagnosing Dementia in the Clinic Eric McDade DO Department of Neurology School of Medicine Alzheimer Disease Research Center Disclosures No relevant financial disclosures
More informationIntroduction, use of imaging and current guidelines. John O Brien Professor of Old Age Psychiatry University of Cambridge
Introduction, use of imaging and current guidelines John O Brien Professor of Old Age Psychiatry University of Cambridge Why do we undertake brain imaging in AD and other dementias? Exclude other causes
More informationDiffusion Tensor Imaging in Dementia. Howard Rosen UCSF Department of Neurology Memory and Aging Center
Diffusion Tensor Imaging in Dementia Howard Rosen UCSF Department of Neurology Memory and Aging Center www.memory.ucsf.edu Overview Examples of DTI findings in Alzheimer s disease And other dementias Explore
More informationMild Cognitive Impairment (MCI)
October 19, 2018 Mild Cognitive Impairment (MCI) Yonas E. Geda, MD, MSc Professor of Neurology and Psychiatry Consultant, Departments of Psychiatry & Psychology, and Neurology Mayo Clinic College of Medicine
More informationDementia and Healthy Ageing : is the pathology any different?
Dementia and Healthy Ageing : is the pathology any different? Professor David Mann, Professor of Neuropathology, University of Manchester, Hope Hospital, Salford DEMENTIA Loss of connectivity within association
More informationNeuroimaging Biomarkers of Neurodegenerative Diseases and Dementia
386 Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia Shannon L. Risacher, PhD 1 Andrew J. Saykin, PsyD 1 1 Center for Neuroimaging, Department of Radiology and Imaging Sciences, and Indiana
More informationDEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD
DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD OBJECTIVES Terminology/Dementia Basics Most Common Types Defining features Neuro-anatomical/pathological underpinnings Neuro-cognitive
More informationWHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient
DEMENTIA WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient Progressive and disabling Not an inherent aspect of
More informationRegulatory Challenges across Dementia Subtypes European View
Regulatory Challenges across Dementia Subtypes European View Population definition including Early disease at risk Endpoints in POC studies Endpoints in pivotal trials 1 Disclaimer No CoI The opinions
More informationLecture 42: Final Review. Martin Wessendorf, Ph.D.
Lecture 42: Final Review Martin Wessendorf, Ph.D. Lecture 33 cortex Heilbronner 5 lobes of the cortex Lateral view (left side) Mid-saggital view (right side) Cellular organization of cortex White matter
More informationRole of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases
Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases Keith A. Josephs, MD, MST, MSc Professor of Neurology 13th Annual Mild Cognitive Impairment (MCI) Symposium: Alzheimer and Non-Alzheimer
More informationParkinson e decadimento cognitivo. Stelvio Sestini
Parkinson e decadimento cognitivo Stelvio Sestini Patients with PD can develop a spectrum of cognitive symptoms Heterogeneity of cognitive deficits The cognitive symptoms can evolve to dementia (Mov Disorder
More informationDr Fiona Kumfor University of Sydney
Social Cognition in Dementia: Informing Diagnosis, Prognosis and Management Dr Fiona Kumfor University of Sydney CHANGES IN DEMENTIA Memory Social cognition Language ELEMENTS OF SOCIAL COGNITION Face processing
More informationClinical Genetics & Dementia
Clinical Genetics & Dementia Dr Nayana Lahiri Consultant in Clinical Genetics & Honorary Senior Lecturer Nayana.lahiri@nhs.net Aims of the Session To appreciate the potential utility of family history
More informationUSE OF BIOMARKERS TO DISTINGUISH SUBTYPES OF DEMENTIA. SGEC Webinar Handouts 1/18/2013
Please visit our website for more information http://sgec.stanford.edu/ SGEC Webinar Handouts 1/18/2013 2013 WEBINAR SERIES STATE OF THE SCIENCE: DEMENTIA EVALUATION AND MANAGEMENT AMONG DIVERSE OLDER
More information212 Index C-SB-13,
Index A Acetylcholinesterase inhibitor, treatment, 15 Age-associated memory impairment (AAMI), 5 Alzheimer s disease (AD), 40, 95 96 apolipoprotein E genotype and risk for, 58 cellular neurodegeneration
More informationDementia and Alzheimer s disease
Since 1960 Medicine Korat โรงพยาบาลมหาราชนครราชส มา Dementia and Alzheimer s disease Concise Reviews PAWUT MEKAWICHAI MD DEPARTMENT of MEDICINE MAHARAT NAKHON RATCHASIMA HOSPITAL 1 Prevalence Increase
More informationCaring Sheet #11: Alzheimer s Disease:
CARING SHEETS: Caring Sheet #11: Alzheimer s Disease: A Summary of Information and Intervention Suggestions with an Emphasis on Cognition By Shelly E. Weaverdyck, PhD Introduction This caring sheet focuses
More informationSupplementary Online Content
Supplementary Online Content Devenney E, Bartley L, Hoon C, et al. Progression in behavioral variant frontotemporal dementia: a longitudinal study. JAMA Neurol. Published online October 26, 2015. doi:10.1001/jamaneurol.2015.2061.
More informationI do not have any disclosures
Alzheimer s Disease: Update on Research, Treatment & Care Clinicopathological Classifications of FTD and Related Disorders Keith A. Josephs, MST, MD, MS Associate Professor & Consultant of Neurology Mayo
More informationDo not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009
Sandra Weintraub, Ph.D. Clinical Core Director, Cognitive Neurology and Alzheimer s Disease Center Northwestern University Feinberg School of Medicine Chicago, Illinois Dementia: a condition caused by
More informationVascular Dementia. Laura Pedelty, PhD MD The University of Illinois at Chicago and Jesse Brown VA Medical Center
Vascular Dementia Laura Pedelty, PhD MD The University of Illinois at Chicago and Jesse Brown VA Medical Center none Disclosures Objectives To review the definition of Vascular Cognitive Impairment (VCI);
More informationSecondary prevention of Alzheimer s dementia: neuroimaging contributions
ten Kate et al. Alzheimer's Research & Therapy (2018) 10:112 https://doi.org/10.1186/s13195-018-0438-z RESEARCH Open Access Secondary prevention of Alzheimer s dementia: neuroimaging contributions Mara
More informationFrontotemporal Dementia: Towards better diagnosis. Frontotemporal Dementia. John Hodges, NeuRA & University of New South Wales, Sydney.
I.1 I.2 II.1 II.2 II.3 II.4 II.5 II.6 III.1 III.2 III.3 III.4 III.5 III.6 III.7 III.8 III.9 III.10 III.11 III.12 IV.1 IV.2 IV.3 IV.4 IV.5 Frontotemporal Dementia: Towards better diagnosis Frontotemporal
More informationDiabetes Mellitus and Dementia. Andrea Shelton & Adena Zadourian
Diabetes Mellitus and Dementia Andrea Shelton & Adena Zadourian Abstract Diabetes mellitus increases the risk for developing dementia...but there is inconsistency with the subtypes of dementia Diabetes
More informationSynaptic changes in dementia: links to cognition and behaviour
Synaptic changes in dementia: links to cognition and behaviour Paul T Francis, PhD Professor of Neurochemistry Director, Brains for Dementia Research Agenda Discuss synaptic changes in various dementias
More informationNeuroimaging for dementia diagnosis. Guidance from the London Dementia Clinical Network
Neuroimaging for dementia diagnosis Guidance from the London Dementia Clinical Network Authors Dr Stephen Orleans-Foli Consultant Psychiatrist, West London Mental Health NHS Trust Dr Jeremy Isaacs Consultant
More informationDementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota
Dementia Update Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Nothing to disclose Dementia Progressive deterioration in mental function
More informationThe current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease
The current state of healthcare for Normal Aging, g, Mild Cognitive Impairment, & Alzheimer s Disease William Rodman Shankle, MS MD FACP Director, Alzheimer s Program, Hoag Neurosciences Institute Neurologist,
More informationThe Role of Cognitive Reserve in the clinical presentation of Alzheimer s Disease Dorene M. Rentz, PsyD
The Role of Cognitive Reserve in the clinical presentation of Alzheimer s Disease Dorene M. Rentz, PsyD Division of Cognitive and Behavioral Neurology, Brigham and Women s Hospital Co-Director of the Center
More informationCEREBRUM. Dr. Jamila EL Medany
CEREBRUM Dr. Jamila EL Medany Objectives At the end of the lecture, the student should be able to: List the parts of the cerebral hemisphere (cortex, medulla, basal nuclei, lateral ventricle). Describe
More informationClinical, molecular imaging and biomarker concordance in the diagnosis of Alzheimer s disease and vascular dementia
Clinical, molecular imaging and biomarker concordance in the diagnosis of Alzheimer s disease and vascular dementia Venugopalan Y Vishnu 1, Manish Modi 1, Jitender Gairolla 1, Ashok Kumar 1, Manju Mohanty
More information! slow, progressive, permanent loss of neurologic function.
UBC ! slow, progressive, permanent loss of neurologic function.! cause unknown.! sporadic, familial or inherited.! degeneration of specific brain region! clinical syndrome.! pathology: abnormal accumulation
More informationFTD basics! Etienne de Villers-Sidani, MD!
FTD basics! Etienne de Villers-Sidani, MD! Frontotemporal lobar degeneration (FTLD) comprises 3 clinical syndromes! Frontotemporal dementia (behavioral variant FTD)! Semantic dementia (temporal variant
More informationRecommendations for the Diagnosis and Treatment of Dementia 2012
Recommendations for the Diagnosis and Treatment of Dementia 2012 Based on the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (4 th CCCDTD) 2012 Gauthier S, Patterson C, Chertkow
More informationAssessing and Managing the Patient with Cognitive Decline
Assessing and Managing the Patient with Cognitive Decline Center of Excellence For Alzheimer s Disease for State of NY Capital Region Alzheimer s Center of Albany Medical Center Earl A. Zimmerman, MD Professor
More informationUpdate on functional brain imaging in Movement Disorders
Update on functional brain imaging in Movement Disorders Mario Masellis, MSc, MD, FRCPC, PhD Assistant Professor & Clinician-Scientist Sunnybrook Health Sciences Centre University of Toronto 53 rd CNSF
More informationNew life Collage of nursing Karachi
New life Collage of nursing Karachi Presenter: Zafar ali shah Faculty: Raja khatri Subject: Pathophysiology Topic :Alzheimer s Disease Post RN BScN semester 2 nd Objective Define Alzheimer s Describe pathophysiology
More informationSupplementary Online Material Supplementary Table S1 to S5 Supplementary Figure S1 to S4
Supplementary Online Material Supplementary Table S1 to S5 Supplementary Figure S1 to S4 Table S1: Brain regions involved in the adapted classification learning task Brain Regions x y z Z Anterior Cingulate
More informationEarly Diagnosis of Alzheimer s Disease and MCI via Imaging and Pattern Analysis Methods. Christos Davatzikos, Ph.D.
Early Diagnosis of Alzheimer s Disease and MCI via Imaging and Pattern Analysis Methods Christos Davatzikos, Ph.D. Director, Section of Biomedical Image Analysis Professor of Radiology http://www.rad.upenn.edu/sbia
More informationDelirium & Dementia. Nicholas J. Silvestri, MD
Delirium & Dementia Nicholas J. Silvestri, MD Outline Delirium vs. Dementia Neural pathways relating to consciousness Encephalopathy Stupor Coma Dementia Delirium vs. Dementia Delirium Abrupt onset Lasts
More informationDiagnosis and management of non-alzheimer dementias. Melissa Yu, M.D. Department of Neurology
Diagnosis and management of non-alzheimer dementias Melissa Yu, M.D. Department of Neurology AGENDA Introduction When to think of alternate diagnoses Other forms of dementia Other reasons for confusion
More informationAmsterdam Dementia Cohort: Performing Research to Optimize Care
Journal of Alzheimer s Disease 62 (2018) 1091 1111 DOI 10.3233/JAD-170850 IOS Press Review 1091 Amsterdam Dementia Cohort: Performing Research to Optimize Care Wiesje M. van der Flier a,b, and Philip Scheltens
More informationProbable Early-onset Alzheimer s Disease Diagnosed by Comprehensive Evaluation and Neuroimage Studies
Case Report Taiwanese Journal of Psychiatry (Taipei) Vol. 25 No. 1 2011 45 Probable Early-onset Alzheimer s Disease Diagnosed by Comprehensive Evaluation and Neuroimage Studies Sin-Yi Chen, M.D. 1, Yuan-Han
More informationA Fresh View of Cognitive Disorders in Older Adults: New Classification and Screening Strategies
A Fresh View of Cognitive Disorders in Older Adults: New Classification and Screening Strategies Lynda Mackin, PhD, AGPCNP-BC, CNS University of California San Francisco School of Nursing 1 Alzheimer s
More informationVisual Dysfunction in Alzheimer s Disease and Parkinson s Disease
Visual Dysfunction in Alzheimer s Disease and Parkinson s Disease Victoria S. Pelak, MD Professor of Neurology and Ophthalmology Divisions of Neuro-ophthalmology and Behavioral Neurology University of
More informationClinical Applications of fmri
Clinical Applications of fmri Benjamin M. Hampstead, Ph.D., ABPP/CN Associate Professor Department of Psychiatry University of Michigan VA Ann Arbor Healthcare System No Disclosures or Conflicts Hampstead
More informationDiagnosis and Treatment of Alzhiemer s Disease
Diagnosis and Treatment of Alzhiemer s Disease Roy Yaari, MD, MAS Director, Memory Disorders Clinic, Banner Alzheimer s Institute 602-839-6900 Outline Introduction Alzheimer s disease (AD)Guidelines -revised
More informationOLD AGE PSYCHIATRY. Dementia definition TYPES OF DEMENTIA. Other causes. Psychiatric disorders of the elderly. Dementia.
Psychiatric disorders of the elderly OLD AGE PSYCHIATRY Dementia Depression Delusional disorder/late onset schizophrenia Delirium Dementia definition LOCALISATION OF CEREBRAL FUNCTION Impairment of multiple
More informationProf Tim Anderson. Neurologist University of Otago Christchurch
Prof Tim Anderson Neurologist University of Otago Christchurch Tim Anderson Christchurch Insidious cognitive loss From subjective memory complaints (SMC) to dementia Case 1. AR. 64 yrs Male GP referral
More informationDementia. Jeanette Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine
Dementia Jeanette Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine What is Dementia? Dementia is a general term referring to a decline in cognitive/mental functioning; this decline
More informationType 2 Diabetes and Brain Disease in Older Adults. Erin L. Abner, PhD, MPH Asst. Professor University Of Kentucky
Type 2 Diabetes and Brain Disease in Older Adults Erin L. Abner, PhD, MPH Asst. Professor University Of Kentucky Disclosures to Participants Requirements for Successful Completion: For successful completion,
More informationAssessing Cognition. Andreana Haley, Ph.D. Department of Psychology University of Texas at Austin
Assessing Cognition Andreana Haley, Ph.D. Department of Psychology University of Texas at Austin Agenda Topic: Cognitive Aging Assessing Cognition Diagnosing Cognitive Impairment Dementia Diagnoses Symptoms
More informationOutline. Facts and figures Action plans Early / correct diagnosis Conclusions
Outline Facts and figures Action plans Early / correct diagnosis Conclusions Dementia: the greatest chalenge. Time to act now Philip Scheltens Professor of Neurology VU University Medical Center Amsterdam
More informationcorrelates with social context behavioral adaptation.
REVIEW OF FRONTAL LOBE STRUCTURES Main organization of frontal cortex: 1. Motor area (precentral gyrus). 2. Premotor & supplementary motor areas (immediately anterior to motor area). Includes premotor,
More informationThe frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer
The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer MRC Clinician Scientist Honorary Consultant Neurologist Dementia Research Centre, UCL Institute of Neurology
More informationImaging biomarkers for Parkinson s disease
3 rd Congress of the European Academy of Neurology Amsterdam, The Netherlands, June 24 27, 2017 Teaching Course 6 MDS-ES/EAN: Neuroimaging in movement disorders - Level 2 Imaging biomarkers for Parkinson
More informationIs PET/CT really helpful in diagnosing Alzheimer s Disease?
Is PET/CT really helpful in diagnosing Alzheimer s Disease? J. Rudolf MD Ph.D. Consultant in Neurology, Dept. of Neurology, General Hospital Papageorgiou Thessaloniki, Greece Conflict of Interest PET/CT
More informationHow can the new diagnostic criteria improve patient selection for DM therapy trials
How can the new diagnostic criteria improve patient selection for DM therapy trials Amsterdam, August 2015 Bruno Dubois Head of the Dementia Research Center (IMMA) Director of INSERM Research Unit (ICM)
More informationPathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)
Pathogenesis of Degenerative Diseases and Dementias D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) Dementias Defined: as the development of memory impairment and other cognitive deficits
More informationbrain MRI for neuropsychiatrists: what do you need to know
brain MRI for neuropsychiatrists: what do you need to know Christoforos Stoupis, MD, PhD Department of Radiology, Spital Maennedorf, Zurich & Inselspital, University of Bern, Switzerland c.stoupis@spitalmaennedorf.ch
More informationNeuroimaging in Dementia
Outline Neuroimaging in Dementia Frederik Barkhof Dept of Radiology & Nuclear Medicine VUMC Amsterdam NL Institutes of Neurology & Biomedical Engineering UCL London UK f.barkhof@vumc.nl; f.barkhof@ucl.ac.uk
More informationNon Alzheimer Dementias
Non Alzheimer Dementias Randolph B Schiffer Department of Neuropsychiatry and Behavioral Science Texas Tech University Health Sciences Center 9/11/2007 Statement of Financial Disclosure Randolph B Schiffer,,
More informationDifferential diagnosis of Frontotemporal Dementia FTLD using visual rating scales
Differential diagnosis of Frontotemporal Dementia FTLD using visual rating scales Poster No.: C-0491 Congress: ECR 2016 Type: Scientific Exhibit Authors: S. Manouvelou 1, G. ANYFANTAKIS 2, V. Koutoulidis
More informationUNIVERSITY OF WESTERN ONTARIO
UNIVERSITY OF WESTERN ONTARIO Vladimir Hachinski, CM, MD, FRCPC, DSc Department of Clinical Neurological Sciences University of Western Ontario London, Ontario, Canada Vladimir.hachinski@lhsc.on.ca ALZHEIMER
More informationDifferential Diagnosis
Differential Diagnosis 2 2.1 Introduction AD accounts for up to 75 % of all dementia cases. The differential diagnosis with other conditions is sometimes challenging since several disorders may produce
More informationVisual Rating Scale Reference Material. Lorna Harper Dementia Research Centre University College London
Visual Rating Scale Reference Material Lorna Harper Dementia Research Centre University College London Background The reference materials included in this document were compiled and used in relation to
More informationDementia. Dr Maria Foundas Consultant Physician. Training support Skills development Competency Assessment Scholarships Education
Dementia Dr Maria Foundas Consultant Physician Training support Skills development Competency Assessment Scholarships Education Preamble and disclaimer These slides are made available by the Western Australian
More informationMRI of Pathological Aging Brain
MRI of Pathological Aging Brain Yukio Miki Department of Radiology, Osaka City University A variety of pathological changes occur in the brain with aging, and many of these changes can be identified by
More informationDiagnosis of Alzheimer s Disease with [18F]PET in Mild and Asymptomatic Stages
Diagnosis of Alzheimer s Disease with [18F]PET in Mild and Asymptomatic Stages The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.
More informationAssessment at the bedside or in the clinic using the history, examination and laboratory tests to distinguish between different types of dementia
Assessment at the bedside or in the clinic using the history, examination and laboratory tests to distinguish between different types of dementia AP Passmore Content Common dementia syndromes (older people)
More informationAn integrated natural disease progression model of nine cognitive and biomarker endpoints in patients with Alzheimer s Disease
An integrated natural disease progression model of nine cognitive and biomarker endpoints in patients with Alzheimer s Disease Angelica Quartino 1* Dan Polhamus 2*, James Rogers 2, Jin Jin 1 212, Genentech
More informationDEMENTIA 9/29/16. Introduction. Introduction. Signs and Symptom. Epidemiology. Dementia. Dr. Yotin Chinvarun M.D. Ph.D.
Introduction DEMENTIA Dr. Yotin Chinvarun M.D. Ph.D. Neurology, Pramongkutklao hospital In 1901 Auguste Deter, a woman in her early 50s, became 1 st person diagnosed with Alzheimer's disease, a form of
More informationCEREBRUM Dr. Jamila Elmedany Dr. Essam Eldin Salama
CEREBRUM Dr. Jamila Elmedany Dr. Essam Eldin Salama Objectives At the end of the lecture, the student should be able to: List the parts of the cerebral hemisphere (cortex, medulla, basal nuclei, lateral
More informationSUPPLEMENTARY INFORMATION In format provided by Frank et al. (JULY 2010)
Table 1 Imaging bios for Alzheimer s Visual rating High correlation with Multicenter studies have Accuracy for longitudinal hippocampus volume (R 2 been performed, but changes only at chance about 0.9,
More informationNeuro-Imaging in dementia: using MRI in routine work-up Prof. Philip Scheltens
Neuro-Imaging in dementia: Philip Scheltens Alzheimer Center VU University Medical Center Amsterdam The Netherlands 1 Outline of talk Current guidelines Imaging used to exclude disease Specific patterns
More informationPart 2: Early detection, assessment and treatment in relation to the new guidelines. Christopher Patterson McMaster University
Part 2: Early detection, assessment and treatment in relation to the new guidelines Christopher Patterson McMaster University C. Patterson MD, FRCPC Division of Geriatric Medicine, McMaster University
More informationThe ABCs of Dementia Diagnosis
The ABCs of Dementia Diagnosis Dr. Robin Heinrichs, Ph.D., ABPP Board Certified Clinical Neuropsychologist Associate Professor, Psychiatry & Behavioral Sciences Director of Neuropsychology Training What
More informationNuclear neurology. Zámbó Katalin Department of Nuclear Medicine
Nuclear neurology Zámbó Katalin Department of Nuclear Medicine To refresh your memory Brain has a high rate of oxidative metabolism. It has no reserves either of oxygen or of glucose and has a very limited
More information3.3. Cerebral perfusion in the predementia stages of Alzheimer s disease
3.3 Cerebral perfusion in the predementia stages of Alzheimer s disease Maja A.A. Binnewijzend, Joost P.A. Kuijer, Marije R. Benedictus, Wiesje M. van der Flier, Charlotte E. Teunissen, Niels D. Prins,
More informationCerebral correlates of psychotic syndromes in neurodegenerative diseases
J. Cell. Mol. Med. Vol 16, No 5, 2012 pp. 995-1012 Cerebral correlates of psychotic syndromes in neurodegenerative diseases Kurt A. Jellinger Institute of Clinical Neurobiology, Vienna, Austria Received:
More informationPRESERVE: How intensively should we treat blood pressure in established cerebral small vessel disease? Guide to assessing MRI scans
PRESERVE: How intensively should we treat blood pressure in established cerebral small vessel disease? Guide to assessing MRI scans Inclusion Criteria Clinical syndrome Patients must have clinical evidence
More information8/14/2018. The Evolving Concept of Alzheimer s Disease. Epochs of AD Research. Diagnostic schemes have evolved with the research
The Evolving Concept of Alzheimer s Disease David S. Geldmacher, MD, FACP Warren Family Endowed Chair in Neurology Department of Neurology UAB School of Medicine Epochs of AD Research Epoch Years Key Event
More informationProvider Led Entity. CDI Quality Institute PLE Neurocognitive Disorders AUC 02/05/2019
Provider Led Entity CDI Quality Institute PLE Neurocognitive Disorders AUC 02/05/2019 Appropriateness of advanced imaging procedures* in patients with a suspected neurocognitive disorder: *Including MRI,
More informationLANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION
LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION Murray Grossman University of Pennsylvania Support from NIH (AG17586, AG15116, NS44266, NS35867, AG32953, AG38490), IARPA, ALS Association, and the
More information